Hyperkalaemia Treatment Market, Global Outlook and Forecast 2022-2028

July 2024 | 62 pages | ID: H8544E775194EN
Market Monitor Global

Abstracts

Hyperkalaemia is a disease in which the levels of potassium are higher than normal. Minerals including potassium are essential for the body and are required for the normal functioning of the cells. The kidneys are responsible for the maintenance of potassium content in the body by balancing its intake as well as its excretion. If the intake of potassium is higher than the ability of the kidney to excrete it or if the functioning of the kidney decreases, hyperkalaemia is likely to occur.

This report contains market size and forecasts of Hyperkalaemia Treatment in Global, including the following market information:

Global Hyperkalaemia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hyperkalaemia Treatment market was valued at 555.6 million in 2021 and is projected to reach US$ 1944.9 million by 2028, at a CAGR of 19.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hyperkalaemia Treatment include Steadfast MediShield, RSM Kilitch Pharma, Perrigo Company, Carolina Medical Products, Novel Laboratories, Pharmascience, Eli Lilly and Company, Relypsa and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hyperkalaemia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hyperkalaemia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hyperkalaemia Treatment Market Segment Percentages, by Type, 2021 (%)

• Oral
• Injections

Global Hyperkalaemia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hyperkalaemia Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacies
• Drug Stores
• Online Pharmacy
• Others

Global Hyperkalaemia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hyperkalaemia Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hyperkalaemia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hyperkalaemia Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Steadfast MediShield
• RSM Kilitch Pharma
• Perrigo Company
• Carolina Medical Products
• Novel Laboratories
• Pharmascience
• Eli Lilly and Company
• Relypsa
• AstraZeneca
• AdvaCare Pharma
• Concordia Pharmaceuticals
• Klarvoyant Biogenics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hyperkalaemia Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hyperkalaemia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HYPERKALAEMIA TREATMENT OVERALL MARKET SIZE

2.1 Global Hyperkalaemia Treatment Market Size: 2021 VS 2028
2.2 Global Hyperkalaemia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hyperkalaemia Treatment Players in Global Market
3.2 Top Global Hyperkalaemia Treatment Companies Ranked by Revenue
3.3 Global Hyperkalaemia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hyperkalaemia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hyperkalaemia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hyperkalaemia Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Hyperkalaemia Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hyperkalaemia Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hyperkalaemia Treatment Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Injections
4.2 By Type - Global Hyperkalaemia Treatment Revenue & Forecasts
  4.2.1 By Type - Global Hyperkalaemia Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Hyperkalaemia Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Hyperkalaemia Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hyperkalaemia Treatment Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacies
  5.1.4 Drug Stores
  5.1.5 Online Pharmacy
  5.1.6 Others
5.2 By Application - Global Hyperkalaemia Treatment Revenue & Forecasts
  5.2.1 By Application - Global Hyperkalaemia Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Hyperkalaemia Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Hyperkalaemia Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hyperkalaemia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hyperkalaemia Treatment Revenue & Forecasts
  6.2.1 By Region - Global Hyperkalaemia Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Hyperkalaemia Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Hyperkalaemia Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hyperkalaemia Treatment Revenue, 2017-2028
  6.3.2 US Hyperkalaemia Treatment Market Size, 2017-2028
  6.3.3 Canada Hyperkalaemia Treatment Market Size, 2017-2028
  6.3.4 Mexico Hyperkalaemia Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hyperkalaemia Treatment Revenue, 2017-2028
  6.4.2 Germany Hyperkalaemia Treatment Market Size, 2017-2028
  6.4.3 France Hyperkalaemia Treatment Market Size, 2017-2028
  6.4.4 U.K. Hyperkalaemia Treatment Market Size, 2017-2028
  6.4.5 Italy Hyperkalaemia Treatment Market Size, 2017-2028
  6.4.6 Russia Hyperkalaemia Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Hyperkalaemia Treatment Market Size, 2017-2028
  6.4.8 Benelux Hyperkalaemia Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hyperkalaemia Treatment Revenue, 2017-2028
  6.5.2 China Hyperkalaemia Treatment Market Size, 2017-2028
  6.5.3 Japan Hyperkalaemia Treatment Market Size, 2017-2028
  6.5.4 South Korea Hyperkalaemia Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Hyperkalaemia Treatment Market Size, 2017-2028
  6.5.6 India Hyperkalaemia Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hyperkalaemia Treatment Revenue, 2017-2028
  6.6.2 Brazil Hyperkalaemia Treatment Market Size, 2017-2028
  6.6.3 Argentina Hyperkalaemia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hyperkalaemia Treatment Revenue, 2017-2028
  6.7.2 Turkey Hyperkalaemia Treatment Market Size, 2017-2028
  6.7.3 Israel Hyperkalaemia Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Hyperkalaemia Treatment Market Size, 2017-2028
  6.7.5 UAE Hyperkalaemia Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Steadfast MediShield
  7.1.1 Steadfast MediShield Corporate Summary
  7.1.2 Steadfast MediShield Business Overview
  7.1.3 Steadfast MediShield Hyperkalaemia Treatment Major Product Offerings
  7.1.4 Steadfast MediShield Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.1.5 Steadfast MediShield Key News
7.2 RSM Kilitch Pharma
  7.2.1 RSM Kilitch Pharma Corporate Summary
  7.2.2 RSM Kilitch Pharma Business Overview
  7.2.3 RSM Kilitch Pharma Hyperkalaemia Treatment Major Product Offerings
  7.2.4 RSM Kilitch Pharma Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.2.5 RSM Kilitch Pharma Key News
7.3 Perrigo Company
  7.3.1 Perrigo Company Corporate Summary
  7.3.2 Perrigo Company Business Overview
  7.3.3 Perrigo Company Hyperkalaemia Treatment Major Product Offerings
  7.3.4 Perrigo Company Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.3.5 Perrigo Company Key News
7.4 Carolina Medical Products
  7.4.1 Carolina Medical Products Corporate Summary
  7.4.2 Carolina Medical Products Business Overview
  7.4.3 Carolina Medical Products Hyperkalaemia Treatment Major Product Offerings
  7.4.4 Carolina Medical Products Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.4.5 Carolina Medical Products Key News
7.5 Novel Laboratories
  7.5.1 Novel Laboratories Corporate Summary
  7.5.2 Novel Laboratories Business Overview
  7.5.3 Novel Laboratories Hyperkalaemia Treatment Major Product Offerings
  7.5.4 Novel Laboratories Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.5.5 Novel Laboratories Key News
7.6 Pharmascience
  7.6.1 Pharmascience Corporate Summary
  7.6.2 Pharmascience Business Overview
  7.6.3 Pharmascience Hyperkalaemia Treatment Major Product Offerings
  7.6.4 Pharmascience Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.6.5 Pharmascience Key News
7.7 Eli Lilly and Company
  7.7.1 Eli Lilly and Company Corporate Summary
  7.7.2 Eli Lilly and Company Business Overview
  7.7.3 Eli Lilly and Company Hyperkalaemia Treatment Major Product Offerings
  7.7.4 Eli Lilly and Company Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.7.5 Eli Lilly and Company Key News
7.8 Relypsa
  7.8.1 Relypsa Corporate Summary
  7.8.2 Relypsa Business Overview
  7.8.3 Relypsa Hyperkalaemia Treatment Major Product Offerings
  7.8.4 Relypsa Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.8.5 Relypsa Key News
7.9 AstraZeneca
  7.9.1 AstraZeneca Corporate Summary
  7.9.2 AstraZeneca Business Overview
  7.9.3 AstraZeneca Hyperkalaemia Treatment Major Product Offerings
  7.9.4 AstraZeneca Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.9.5 AstraZeneca Key News
7.10 AdvaCare Pharma
  7.10.1 AdvaCare Pharma Corporate Summary
  7.10.2 AdvaCare Pharma Business Overview
  7.10.3 AdvaCare Pharma Hyperkalaemia Treatment Major Product Offerings
  7.10.4 AdvaCare Pharma Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.10.5 AdvaCare Pharma Key News
7.11 Concordia Pharmaceuticals
  7.11.1 Concordia Pharmaceuticals Corporate Summary
  7.11.2 Concordia Pharmaceuticals Business Overview
  7.11.3 Concordia Pharmaceuticals Hyperkalaemia Treatment Major Product Offerings
  7.11.4 Concordia Pharmaceuticals Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.11.5 Concordia Pharmaceuticals Key News
7.12 Klarvoyant Biogenics
  7.12.1 Klarvoyant Biogenics Corporate Summary
  7.12.2 Klarvoyant Biogenics Business Overview
  7.12.3 Klarvoyant Biogenics Hyperkalaemia Treatment Major Product Offerings
  7.12.4 Klarvoyant Biogenics Hyperkalaemia Treatment Revenue in Global Market (2017-2022)
  7.12.5 Klarvoyant Biogenics Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hyperkalaemia Treatment Market Opportunities & Trends in Global Market
Table 2. Hyperkalaemia Treatment Market Drivers in Global Market
Table 3. Hyperkalaemia Treatment Market Restraints in Global Market
Table 4. Key Players of Hyperkalaemia Treatment in Global Market
Table 5. Top Hyperkalaemia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hyperkalaemia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hyperkalaemia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hyperkalaemia Treatment Product Type
Table 9. List of Global Tier 1 Hyperkalaemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hyperkalaemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hyperkalaemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hyperkalaemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hyperkalaemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hyperkalaemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hyperkalaemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hyperkalaemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hyperkalaemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hyperkalaemia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hyperkalaemia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hyperkalaemia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hyperkalaemia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hyperkalaemia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hyperkalaemia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hyperkalaemia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Steadfast MediShield Corporate Summary
Table 31. Steadfast MediShield Hyperkalaemia Treatment Product Offerings
Table 32. Steadfast MediShield Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. RSM Kilitch Pharma Corporate Summary
Table 34. RSM Kilitch Pharma Hyperkalaemia Treatment Product Offerings
Table 35. RSM Kilitch Pharma Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Perrigo Company Corporate Summary
Table 37. Perrigo Company Hyperkalaemia Treatment Product Offerings
Table 38. Perrigo Company Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Carolina Medical Products Corporate Summary
Table 40. Carolina Medical Products Hyperkalaemia Treatment Product Offerings
Table 41. Carolina Medical Products Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Novel Laboratories Corporate Summary
Table 43. Novel Laboratories Hyperkalaemia Treatment Product Offerings
Table 44. Novel Laboratories Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Pharmascience Corporate Summary
Table 46. Pharmascience Hyperkalaemia Treatment Product Offerings
Table 47. Pharmascience Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly and Company Corporate Summary
Table 49. Eli Lilly and Company Hyperkalaemia Treatment Product Offerings
Table 50. Eli Lilly and Company Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Relypsa Corporate Summary
Table 52. Relypsa Hyperkalaemia Treatment Product Offerings
Table 53. Relypsa Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)
Table 54. AstraZeneca Corporate Summary
Table 55. AstraZeneca Hyperkalaemia Treatment Product Offerings
Table 56. AstraZeneca Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)
Table 57. AdvaCare Pharma Corporate Summary
Table 58. AdvaCare Pharma Hyperkalaemia Treatment Product Offerings
Table 59. AdvaCare Pharma Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Concordia Pharmaceuticals Corporate Summary
Table 61. Concordia Pharmaceuticals Hyperkalaemia Treatment Product Offerings
Table 62. Concordia Pharmaceuticals Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Klarvoyant Biogenics Corporate Summary
Table 64. Klarvoyant Biogenics Hyperkalaemia Treatment Product Offerings
Table 65. Klarvoyant Biogenics Hyperkalaemia Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hyperkalaemia Treatment Segment by Type in 2021
Figure 2. Hyperkalaemia Treatment Segment by Application in 2021
Figure 3. Global Hyperkalaemia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hyperkalaemia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hyperkalaemia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hyperkalaemia Treatment Revenue in 2021
Figure 8. By Type - Global Hyperkalaemia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hyperkalaemia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hyperkalaemia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hyperkalaemia Treatment Revenue Market Share, 2017-2028
Figure 12. US Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hyperkalaemia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hyperkalaemia Treatment Revenue Market Share, 2017-2028
Figure 24. China Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hyperkalaemia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hyperkalaemia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hyperkalaemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Steadfast MediShield Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. RSM Kilitch Pharma Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Perrigo Company Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Carolina Medical Products Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novel Laboratories Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pharmascience Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly and Company Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Relypsa Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. AstraZeneca Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. AdvaCare Pharma Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Concordia Pharmaceuticals Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Klarvoyant Biogenics Hyperkalaemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)